Discover Tenders by Pharmaceutical Articles Sector

Find the most relevant tenders for Pharmaceutical Articles. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Pharmaceutical Articles tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Pharmaceutical Articles tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pilocarpine

Deadline: 10 May 2026

Germany

Ref. No.: 6590432

EMD:Ref Document

Bid Value: Ref Document

154 Days Left

Dynamic Acquisition System For The Purchase Of Used And New Vehicles 2024 2028

Deadline: 21 Jun 2028

France

Ref. No.: 6551757

EMD:Ref Document

Bid Value: Ref Document

927 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6479528

EMD:Ref Document

Bid Value: Ref Document

389 Days Left

Open House Biologics Discount Agreements 2024 04 Follitropin Alfa

Deadline: 31 Jul 2026

Germany

Ref. No.: 6465353

EMD:Ref Document

Bid Value: Ref Document

236 Days Left

Open House Biologics Discount Agreements 2024 06 Peginterferon Beta 1A

Deadline: 31 Jul 2026

Germany

Ref. No.: 6448272

EMD:Ref Document

Bid Value: Ref Document

236 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For Ws Lanthanum Iii Carbonate In The Dosage Form Of Chewable Tablets Atc Code According To Who V0

Deadline: 31 Jul 2026

Germany

Ref. No.: 6417253

EMD:Ref Document

Bid Value: Ref Document

236 Days Left

Medicines Containing The Active Ingredient Lisdexamfetamine Atc N06Ba12

Deadline: 31 May 2026

Germany

Ref. No.: 6409194

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Open House Biologics Discount Agreements 2024 08 Darbepoetin Alfa

Deadline: 31 Jul 2026

Germany

Ref. No.: 6400034

EMD:Ref Document

Bid Value: Ref Document

236 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Clonazepam Atc N03Ae01 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6374267

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olanzapine Excl Dafo For The Production Of A Depot Isu Atc N05Ah03 Obo For The Period 01 08 24 31 07 26

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373800

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Naloxegol Atc A06Ah03 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373588

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bimatoprost Timolol Exclusively Edo Atc S01Ed62 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373231

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Open House Drug Rebate Agreements Ustekinumab Atc L04Ac05

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373143

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6371060

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ustekinumab Atc L04Ac05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369929

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Showing 19456 to 19470 of 19716 results

‹
1
2
...
1295
1296
1297
1298
1299
1300
1301
...
1314
1315
›

Discover Tenders by Pharmaceutical Articles Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Articles Sector

Filter Your Search

FREE Trial plan for all new users!